Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Deletion of a tripeptide sequence from the growth-factor domain of tissue-type plasminogen activator prolongs in vivo circulation.

Thrombosis research - 1 Aug 1990

Browne M J, Chapman C G, Dodd I, Esmail A F, Robinson J H

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amino Acid Sequence
Share to Base Sequence
Share to Binding Sites
Share to DNA

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Growth Substances

Share to Guinea Pigs

Share to Metabolic Clearance Rate

Share to Tissue Plasminogen Activator

Source

Identifiers

PMID: 2122547
DOI: 10.1016/0049-3848(90)90429-g

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Deletion of a tripeptide sequence from the growth-factor domain of tissue-type plasminogen activator prolongs in vivo circulation.PMID 2122547Read ↗

Site-directed mutagenesis in human tissue-plasminogen activator. Distinguishing sites in the amino-terminal region required for full fibrinolytic activity and rapid clearance from the circulation.Semantic proximity Read ↗

Tissue plasminogen activator: the biochemistry and pharmacology of variants produced by mutagenesis.Semantic proximity Read ↗

Signal and propeptide processing of human tissue plasminogen activator: activity of a pro-tPA derivative.Semantic proximity Read ↗

Pharmacological and clinical impact of the unique molecular structure of a new plasminogen activator.Semantic proximity Read ↗

Recombinant variants of tissue-type plasminogen activator containing amino acid substitutions in the fibronectin finger-like domain and the kringle 1 domain.Semantic proximity Read ↗

Human tissue-type plasminogen activator.Semantic proximity Read ↗

Remarkable extension of PAI-1 half-life surprisingly brings no changes to its structure.Semantic proximity Read ↗

Molecular biologic modification of plasminogen activators. An artful science.Semantic proximity Read ↗

Tissue-type plasminogen activator: mutants, variants, and adjunctive treatment.Semantic proximity Read ↗

Fibrin affinity and clearance of t-PA deletion and substitution analogues.Semantic proximity Read ↗

The plasminogen activator system: biology and regulationSemantic proximity Read ↗

[New types of plasminogen activators].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.